LGND
Ligand Pharmaceuticals Incorporated
302.70$
-3.1%
vs. previous close
Closing price · As of: Oct 1, 2026
Statements
Cash Flow
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.96 | 1.97 | 3.02 | 3.98 | 8.06 | -1.48 | 3.37 | 4.57 | 8.17 | 2.79 | 5.31 | 2.43 | |
| 0.12 | 0.12 | 0.54 | 0.50 | 0.61 | 2.21 | 1.73 | 2.95 | 3.05 | 2.06 | 1.93 | 1.76 | |
| 0.53 | 0.59 | 0.91 | 1.06 | 0.87 | 1.24 | 1.90 | 2.25 | 3.57 | 1.45 | 2.25 | 2.31 | |
| 0.44 | -9.51 | 2.59 | 3.12 | 0.38 | -36.33 | -0.11 | 0.36 | 2.84 | – | – | – | |
| -0.51 | 0.04 | -0.51 | -0.49 | -1.61 | -0.21 | -0.62 | -3.02 | 3.89 | -1.94 | 1.06 | -0.62 | |
| 0.21 | 0.51 | 1.36 | 0.30 | 0.49 | 0.13 | 0.28 | 0.51 | 1.06 | 3.03 | 1.07 | 0.02 | |
| -0.09 | -5.32 | -6.87 | -3.58 | -17.59 | 23.63 | 14.31 | 1.77 | 9.70 | -0.66 | -7.85 | -18.59 | |
| 0.00 | 0.00 | 0.00 | 0.00 | – | 0.15 | 0.19 | 0.89 | 0.30 | – | – | – | |
| -3.17 | -0.02 | -0.19 | -0.08 | -5.11 | -22.93 | -4.82 | -1.07 | -0.49 | -0.26 | -0.28 | -0.74 | |
| -0.91 | 25.08 | 25.55 | 22.67 | 21.42 | -1.38 | -13.73 | -9.56 | -15.47 | -4.33 | 0.00 | 17.43 | |
| 6.07 | 0.39 | 0.07 | -0.32 | 13.65 | -24.56 | -19.19 | -7.99 | -16.36 | -3.38 | 5.31 | 21.10 | |
| 6.93 | -2.96 | -3.78 | 0.08 | 4.12 | -2.40 | -1.50 | -1.65 | 1.51 | -1.24 | 2.70 | 5.06 | |
| 0.75 | 1.45 | 1.66 | 3.68 | 7.57 | -1.61 | 3.10 | 4.06 | 7.11 | -0.24 | 4.23 | 2.41 |
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.